FDA Cobbles Together Pilot For Remote Review Of Manufacturer Records
Executive Summary
The coming pilot program would give the US FDA remote access to a manufacturer’s records. It’s another approach the agency wants to try as it feels out the best way to virtually evaluate regulatory compliance during the COVID-19 pandemic.